Aethlon Medical, Inc. (AEMD)
NASDAQ: AEMD ยท Real-Time Price ยท USD
4.840
-0.270 (-5.28%)
At close: Nov 19, 2026, 4:00 PM EST
4.840
0.00 (0.00%)
After-hours: Nov 19, 2026, 4:15 PM EST
Aethlon Medical Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
9
Market Cap
7.78M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | - | - | - |
| Mar 31, 2025 | - | - | - |
| Mar 31, 2024 | - | - | - |
| Mar 31, 2023 | 574.25K | 280.08K | 95.21% |
| Mar 31, 2022 | 294.17K | -364.94K | -55.37% |
| Mar 31, 2021 | 659.10K | 8.92K | 1.37% |
| Mar 31, 2020 | 650.19K | 420.56K | 183.15% |
| Mar 31, 2019 | 229.63K | 80.00K | 53.47% |
| Mar 31, 2018 | 149.63K | -242.45K | -61.84% |
| Mar 31, 2017 | 392.07K | -494.50K | -55.78% |
| Mar 31, 2016 | 886.57K | 124.16K | 16.28% |
| Mar 31, 2015 | 762.42K | -861.35K | -53.05% |
| Mar 31, 2014 | 1.62M | 393.77K | 32.01% |
| Mar 31, 2013 | 1.23M | -129.62K | -9.53% |
| Mar 31, 2012 | 1.36M | - | - |
| Mar 31, 2011 | - | - | - |
| Mar 31, 2010 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Trinity Biotech | 43.79M |
| Baird Medical Investment Holdings | 24.49M |
| WORK Medical Technology Group LTD | 10.72M |
| INVO Fertility | 8.00M |
| Intelligent Bio Solutions | 4.50M |
| IceCure Medical | 3.95M |
| VolitionRx | 3.44M |
| 20/20 Biolabs | 2.00M |
AEMD News
- 7 days ago - Aethlon Medical reports Q2 EPS ($2.60) vs. ($18.70) last year - TheFly
- 7 days ago - Aethlon Medical Reports Second Quarter Fiscal 2027 Results and Provides Corporate Update - PRNewsWire
- 7 days ago - Aethlon Medical Quarterly report: Q2 2027 - Filings
- 7 days ago - Aethlon Medical Earnings release: Q2 2027 - Filings
- 7 weeks ago - Aethlon Medical Transcript: AGM 2026 - Transcripts
- 2 months ago - BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Ruger & Company, Inc. (NYSE โ RGR), Atkore, Inc. (NYSE โ ATKR), Centerspace (NYSE โ CSR), Aethlon Medical, Inc. (Nasdaq โ AEMD) - GlobeNewsWire
- 2 months ago - M&A News: Aethlon Medical Stock (AEMD) Rockets 400% After North Immunology Deal to Fight Eczema - TipRanks
- 2 months ago - Aethlon Medical, North Immunology enter all-stock transaction - TheFly